tiprankstipranks
Advertisement
Advertisement

TSE:GSD Stock Latest News

Devonian Refreshes Board and Expands Stock Option Pool at Annual Meeting
Company AnnouncementsDevonian Refreshes Board and Expands Stock Option Pool at Annual Meeting
14d ago
Devonian Health Group Deepens Loss as It Pivots to Thykamine-Focused Drug Development
PremiumCompany Announcements
Devonian Health Group Deepens Loss as It Pivots to Thykamine-Focused Drug Development
19d ago
Devonian’s Thykamine Shows Anti-Fibrotic Promise in Human MASH Liver-on-a-Chip Study
PremiumCompany Announcements
Devonian’s Thykamine Shows Anti-Fibrotic Promise in Human MASH Liver-on-a-Chip Study
2M ago
Devonian Tightens Thykamine IP and Manufacturing Controls With New Chemical Fingerprint
PremiumCompany Announcements
Devonian Tightens Thykamine IP and Manufacturing Controls With New Chemical Fingerprint
2M ago
Devonian’s Thykamine Shows Strong Anti-Fibrotic Gene Effects in MASH Model
PremiumCompany Announcements
Devonian’s Thykamine Shows Strong Anti-Fibrotic Gene Effects in MASH Model
2M ago
Devonian’s Thykamine Shows Strong Antifibrotic Potential in Pulmonary Fibrosis Model
PremiumCompany AnnouncementsDevonian’s Thykamine Shows Strong Antifibrotic Potential in Pulmonary Fibrosis Model
2M ago
Devonian Names New CFO and Clarifies Stock Option Terms After Share Consolidation
Premium
Company Announcements
Devonian Names New CFO and Clarifies Stock Option Terms After Share Consolidation
2M ago
Devonian Health Group Launches 1-for-60 Share Consolidation Ahead of Potential U.S. Listing
Premium
Company Announcements
Devonian Health Group Launches 1-for-60 Share Consolidation Ahead of Potential U.S. Listing
3M ago
Devonian Launches 1-for-60 Reverse Split Ahead of Potential U.S. Listing
PremiumCompany Announcements
Devonian Launches 1-for-60 Reverse Split Ahead of Potential U.S. Listing
3M ago
Devonian Health Group Joins ThinkEquity Conference and Secures Funding
PremiumCompany Announcements
Devonian Health Group Joins ThinkEquity Conference and Secures Funding
6M ago
Devonian Health Group Advances Thykamine™ Development and Updates Private Placement
PremiumCompany Announcements
Devonian Health Group Advances Thykamine™ Development and Updates Private Placement
8M ago
Devonian Health Group Secures $2.27 Million in Private Placement
PremiumCompany Announcements
Devonian Health Group Secures $2.27 Million in Private Placement
8M ago
Devonian Health Group Reports Revenue Growth Amid Strategic Leadership Changes
PremiumCompany AnnouncementsDevonian Health Group Reports Revenue Growth Amid Strategic Leadership Changes
10M ago
Devonian Health Group Resumes Trading on TSXV
Premium
Company Announcements
Devonian Health Group Resumes Trading on TSXV
12M ago
Devonian Health Group Reports Strong Q2 Revenue Growth and Strategic Advances
Premium
Company Announcements
Devonian Health Group Reports Strong Q2 Revenue Growth and Strategic Advances
12M ago
Devonian Health Group Faces Cease Trade Order Amid Filing Delays
PremiumCompany Announcements
Devonian Health Group Faces Cease Trade Order Amid Filing Delays
12M ago
Devonian Health Group Delays Financial Reporting Due to Restatement Needs
PremiumCompany Announcements
Devonian Health Group Delays Financial Reporting Due to Restatement Needs
1y ago
Devonian Health Group Announces Key Approvals at Annual Shareholder Meeting
PremiumCompany Announcements
Devonian Health Group Announces Key Approvals at Annual Shareholder Meeting
1y ago
Devonian Health Group Files Patent for Thykamine™ as Antifibrotic Agent
PremiumCompany Announcements
Devonian Health Group Files Patent for Thykamine™ as Antifibrotic Agent
1y ago
Devonian Health Group Reports Promising Thykamine™ Results in Fibrosis Gene Study
PremiumCompany AnnouncementsDevonian Health Group Reports Promising Thykamine™ Results in Fibrosis Gene Study
1y ago
Devonian Health Group Files Patent for Thykamine™ in Liver Disease Treatment
Premium
Company Announcements
Devonian Health Group Files Patent for Thykamine™ in Liver Disease Treatment
1y ago
Devonian Health Faces Revenue Impact as Dexlansoprazole License Ends
Premium
Company Announcements
Devonian Health Faces Revenue Impact as Dexlansoprazole License Ends
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >